Pay in 4 interest-free payments of $46.03 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
(2004) Expression of a flt-4 (VEGFR3) splicing variant in primary human prostate tumors
Functional Assay Reactivity Ms Purification Protein A Concentration 5 mg/ml Purity ＞95% by SDS-PAGE Endotoxin <1EU/mg Physical Appearance Liquid Storage Buffer PBS pH7
The sample may need to be used with a diluent ( 1× ) dilution
MDR3 dysfunction has been linked to drug-induced liver injury (DILI) due to its inhibition by certain drugs or their metabolites
It is also known as C9-related protein or cytolysin
Human TNFRSF17 ELISA Kit Size:96T (2004) Expression of a flt-4Product Specification Usage Experimental equipment required for the experiment: 1. Microplate reader (450nm) 2. High precision pipette and gun tips: 0. 5 10uL, 5 50uL, 20 200uL, 200 1000uL 3. 37 constant temperature box 4. Distilled water or deionized water Sample processing and requirements: 1. Serum: Place the whole blood sample collected in the serum separation tube at room temperature for 2 hours or at 4 overnight, then centrifuge at 1000g for 20
US$ 229486.00
US$ 44557.00
US$ 39058.00
US$ 34042.50
US$ 40306.00
US$ 41950.00
US$ 39101.50
US$ 32349.50
US$ 19950.00
US$ 39582.00
US$ 38031.50
US$ 30639.50